• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
YUE Juanjuan, CUI Hanyue, WANG Hui, YE Bin, CHEN Dingding. Protective effects of losartan potassium on 5/6 nephrectomy-induced chronic heart failure in rats[J]. Journal of China Pharmaceutical University, 2016, 47(6): 734-739. DOI: 10.11665/j.issn.1000-5048.20160617
Citation: YUE Juanjuan, CUI Hanyue, WANG Hui, YE Bin, CHEN Dingding. Protective effects of losartan potassium on 5/6 nephrectomy-induced chronic heart failure in rats[J]. Journal of China Pharmaceutical University, 2016, 47(6): 734-739. DOI: 10.11665/j.issn.1000-5048.20160617
shu

Protective effects of losartan potassium on 5/6 nephrectomy-induced chronic heart failure in rats

More Information
    Graphical Abstract
    • Abstract
  • The purpose of this research is to investigate the therapeutic effects of losartan potassium on 5/6 nephrectomy rats with chronic heart failure(CHF)and to explore the mechanism. 24 Rats were randomly divided into three groups namely sham group(Sham), pathology group(Nx)and losartan potassium group(Lst), respectively. CHF model in rats were induced by 5/6 nephrectomy. At the 7th week, rats of Lst group were given losartan potassium(50 mg/L)for consecutive 2 weeks. Then all rats were measured for hemodynamic parameters, cardiac index, creatinine, urea nitrogen in serum, and expressions of CD133, VEGFR2, Sox2, cleaved Caspase-3 and Bcl-2 in heart. Compared with Nx group, rats of Lst group improved cardiac and renal functions: decreased LVDP, LVEDP, cardiac index, creatinine, urea nitrogen and increased LVSP. Furthermore, losartan potassium up-regulated gene expression of CD133, VEGFR2, Sox2 and protein level of Bcl-2, and down-regulated cleaved Caspase-3 protein expression. Results suggest that losartan potassium can improve cardiac function of rats with CHF which may be correlated with mobilizing bone marrow stem cells, increasing endothelial progenitor cells(EPCs)level in heart, repairing endothelial function, and inhibiting myocardial apoptosis.
    • FullText(HTML)
    • References (16)
  • [1]
    Unger T,Li J.The role of the renin-angiotensin-aldosterone system in heart failure[J].J Renin Angiotensin Aldosterone Syst,2004,5(Suppl 1):S7-10.
    [2]
    Lund L,Benson L.Losartan vs candesartan for heart failure[J].JAMA,2012,308(4):336-337.
    [3]
    Wang JJ,Chen DD.Cardiorenal syndrome in 5/6 nephrectomized rats[J].Chin J Mod Drug Appl(中国现代药物应用),2009,3(15):1-4.
    [4]
    Remuzzi G,Perico N,Macia M,et al.The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease[J].Kidney Int,2005,68(Suppl 99):S57-65.
    [5]
    Zhao YH,Lu CX,Lei T,et al.The study of angiotensin Ⅱ inducing apoptosis in neonatal rat cardiomyocytes[J].Molecular Cardiol China(中国分子心脏病学杂志),2008,8(2):83-86.
    [6]
    Drexler H.Endothelium as a therapeutic target in heart failure[J].Circulation,1998,98(24):2652-2655.
    [7]
    Thal M,Krishnamurthy P,Mackie A,et al.Enhanced angiogenic and cardiomyocyte differentiation capacity of epigenetically reprogrammed mouse and human endothelial progenitor cells augments their efficacy for ischemic myocardial repair[J].Circ Res,2012,111(2):180-190.
    [8]
    Imanishi T,Hano T,Nishio I.Angiotensin II accelerates endothelial progenitor cell senescence through induction of oxidative stress[J].J Hypertens,2005,23(1):97-104.
    [9]
    Endtmann C, Ebrahimian T, Czech T, et al. AngiotensinⅡ impairs endothelial progenitor cell number and function in vitro and in vivo:implications for vascular regeneration[J].Hypertension,2011,58(3):394-403.
    [10]
    Takahashi K,Yamanaka S.Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors[J].Cell,2006,126(4):663-676.
    [11]
    Rao JH,Zhou X.The key cell factors of stem cells Oct4 and Sox2[J].Prog Veterinary Med(动物医学进展),2012,33(3):114-119.
    [12]
    Liu C,Rong LM,Liu B.Sox2 induce mouse embryonic fibroblasts direct reprogrammin into neural stem cells[J].Chin J Pathophysiol(中国病理生理杂志),2015,31(1):87-92.
    [13]
    Tilling L,Chowienczyk P,Clapp B.Progenitors in motion:the mechanisms of mobilization of endothelial progenitor cells[J].Br J Clin Pharmacol,2009,68(4):484-492.
    [14]
    Kasal DA, Schiffrin EL. Angiotensin II, aldosterone, and anti-inflammatory lymphocytes:interplay and therapeutic opportunities[J].Int J Hypertens,2012,2012:829786.
    [15]
    Marumo T,Uchimura H,Hayashi M,et al.Aldosterone impairs bone marrow-derived progenitor cell formation[J].Hypertension,2006:48(3):490-496.
    [16]
    Yu Y,Fukuda N,Yao EH,et al.Effects of an ARB on endothelial progenitor cell function and cardiovascular oxidation in hypertension[J].Am J Hypertens,2008,21(1):72-77.
    • Related Articles

  • Related Articles

    [1]TU Penghuang, YAO Zhiren, JIN Meiling, NING Guanyu, HUANG Yaping, PAN Ke, YIN Zhiqi. Study of glycosides from Piper sintenense Hatusima[J]. Journal of China Pharmaceutical University, 2024, 55(2): 202-208. DOI: 10.11665/j.issn.1000-5048.2023122704
    [2]CAI Caihong, ZHENG Hao, GAI Cuijuan, DAI Haofu, MEI Wenli, CHEN Huiqin. Secondary metabolites of the endophytic fungus Aspergillus sp.Dq-25 from barnacle[J]. Journal of China Pharmaceutical University, 2023, 54(1): 62-67. DOI: 10.11665/j.issn.1000-5048.20220531001
    [3]FANG Siyang, ZHANG Xinggui, YE Yu, WANG Keqing, YAO Zhiren, HUANG Yaping, ZHANG Jian, QIN Yanhua, YIN Zhiqi. A new ester glycoside compound from Cyclocarya paliurus[J]. Journal of China Pharmaceutical University, 2023, 54(1): 56-61. DOI: 10.11665/j.issn.1000-5048.20221209002
    [4]XIE Jing, FAN Chunlin, XU Jie, ZHANG Jian, YE Wencai, ZHANG Xiaoqi. Alkaloids of Ervatamia pandacaqui[J]. Journal of China Pharmaceutical University, 2021, 52(3): 287-292. DOI: 10.11665/j.issn.1000-5048.20210304
    [5]ZHANG Yilun, ZHAO Xinyi, DONG Shubo, DONG Chao, SHEN Wenbin, DONG Haijuan. Isolation and identification of unknown impurities of alogliptin benzoate[J]. Journal of China Pharmaceutical University, 2020, 51(4): 488-493. DOI: 10.11665/j.issn.1000-5048.20200415
    [6]TAO Junjie, YANG Jie, WEN Xiaodong. Studies on the chemical constituents in the aerial parts of Paris polyphylla var. Yunnanensis[J]. Journal of China Pharmaceutical University, 2020, 51(4): 454-460. DOI: 10.11665/j.issn.1000-5048.20200410
    [7]HUANG Qilong, ZHANG Wanjin, LI Yan, CHEN Juan, ZHOU Baoping, ZOU Xiaohan, ZHANG Chunlei, CAO Zhengyu. Alkaloid constituents from Corydalis decumbens[J]. Journal of China Pharmaceutical University, 2017, 48(5): 563-567. DOI: 10.11665/j.issn.1000-5048.20170509
    [8]WANG Jingyi, DONG Yangyang, QI Chulu, ZHANG Jiayao, ZHANG Minjie, WANG Hao. Chemical constituents of the stem bark of Bombax ceiba L.[J]. Journal of China Pharmaceutical University, 2016, 47(5): 570-574. DOI: 10.11665/j.issn.1000-5048.20160511
    [9]YANG Hanbing, YANG Wenqiang, SONG Min, ZHANG Jian, ZHANG Xiaoqi, YE Wencai. Phenolic constituents of Galla Chinensis and their antiviral activities[J]. Journal of China Pharmaceutical University, 2016, 47(5): 566-569. DOI: 10.11665/j.issn.1000-5048.20160510
    [10]Isolation and Identification of Two Taxane DiterpenoidCompounds[J]. Journal of China Pharmaceutical University, 2001, (3): 32-34.

Catalog

    Get Citation
    PDF
    XML
    Article views (595) PDF downloads (930) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：366183

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return